Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Pilot Study of ACTH in the Treatment of IgA Nephropathy at High Risk of Progression

NCT02282930 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT02282930
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02282930 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Pilot Study of ACTH in the Treatment of IgA Nephropathy at High Risk of Progression
Lead sponsor
Mayo Clinic
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2015
Completion date
June 30, 2018
Enrollment
20 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

progressive iga nephropathy, proteinuria